


The Investment Objective of the Ecclesiastical International Growth Fund is to achieve long-term capital growth with a reasonable level of income.
| Name | % Net Assets | 
|---|---|
| Lonking Holdings | 2.9% | 
| Telefonica S.A. ADS | 2.4% | 
| Roche Holding AG Part. Cert. | 2.4% | 
| StatoilHydro ASA | 2.3% | 
| China Shineway Pharmaceutical Group | 2.3% | 
| Sanofi-Aventis S.A. | 2.1% | 
| Scud Group | 2.1% | 
| GlaxoSmithKline | 2.0% | 
| Swatch Group AG | 1.9% | 
| Novartis | 1.7% | 
| Key | % Net Assets | 
|---|---|
| 2.9% | |
| 2.4% | |
| 2.4% | |
| 2.3% | |
| 90% | 
| Date | 20-Jun-2025 | 
|---|---|
| NAV | 429.90p | 
| Currency | GBP | 
| Change | -0.80p | 
| % | -0.19% | 
| YTD change | -10.50p | 
| YTD % | -2.38% | 
| Fund Inception | 13/09/1999 | 
|---|---|
| Fund Manager | Robin Hepworth | 
| TER | - | 
| Minimum Investment | |
|---|---|
| Initial | £1000000 | 
| Additional | n/a | 
| Savings | £25 | 
| Charges | |
|---|---|
| Initial | 5.00% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.02 | 
| Sharpe ratio | 0.15 | 
You are here: research